Stroke/Vascular Neurology News

Researchers observed differences in survival between antiseizure medications in post-stroke epilepsy, with lamotrigine and levetiracetam appearing to be reasonable first-line treatment options, according to a study in JAMA Neurology.

Anticoagulation with rivaroxaban for patients with atrial fibrillation aged 65 years or more was associated with greater risk for major ischemic and hemorrhagic events compared with apixaban, according to data published in JAMA.

The American Heart Association announced a $10 million initiative to fund studies of long-term effects of COVID-19 on heart and brain health.

Rapid intensive care, including endovascular therapy after stroke, proved to be a factor in less memory loss, according to results of a survey published in the American Academy of Neurology.

Despite a slight decrease in the worldwide incidence and mortality rates for stroke between 1990 and 2019, the overall numbers remain high, according to study results published in Neurology.

A new classification system accurately predicted which patients with ischemic stroke of unknown original might benefit from patent foramen ovale closure.

Patients who present with a low Alberta Stroke Program Early Computed Tomography Score may achieve functional independence following mechanical thrombectomy, according to results of a retrospective cohort study.

The FDA has granted orphan drug designation to NeurOp Inc. for an investigational candidate for treating subarachnoid hemorrhage, according to a company press release.

Dual antiplatelet therapy that combined aspirin with either ticagrelor or clopidogrel outperformed aspirin alone in minor ischemic stroke and transient ischemic attack, according to results of a network meta-analysis.

Men and women with ischemic stroke had improved functional outcomes in the past 2 decades, likely due in part to the development of acute reperfusion therapy, according to results of a prospective, registry cohort study.